Log in
Enquire now
Sensei Biotherapeutics

Sensei Biotherapeutics

Sensei Biotherapeutics is a clinical-stage immunotherapy company that engages in the discovery and development of next generation therapies with a primary focus on the treatments for cancer.

OverviewStructured DataIssuesContributors
Name
# Contributions
Last Contribution
Golden AI profile picture
Golden AI
25
over 1 year ago
Katrina-Kay Pettitt profile picture
Katrina-Kay Pettitt
7
over 2 years ago
Aime Anne Nisay profile picture
Aime Anne Nisay
2
over 6 years ago
Henry Ogolla profile picture
Henry Ogolla
2
over 4 years ago
Kombain Mashina profile picture
Kombain Mashina
2
over 3 years ago
Alexander Baychikov profile picture
Alexander Baychikov
1
about 3 years ago
Amit Gehlot profile picture
Amit Gehlot
1
over 4 years ago
Amy Sar profile picture
Amy Sar
1
almost 2 years ago
Andrey Duzenko profile picture
Andrey Duzenko
1
over 3 years ago
Erin Scherfner profile picture
Erin Scherfner
1
over 4 years ago
Golden Au profile picture
Golden Au
1
over 1 year ago
Keeri Tramm profile picture
Keeri Tramm
1
over 3 years ago
N Ni profile picture
N Ni
1
over 3 years ago
Nureni Akanji profile picture
Nureni Akanji
1
over 4 years ago
Patrick Pum profile picture
Patrick Pum
1
about 3 years ago
Semyon Kolychev profile picture
Semyon Kolychev
1
almost 3 years ago
Wyckliffe Otieno profile picture
Wyckliffe Otieno
1
almost 4 years ago

Find more companies like Sensei Biotherapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.